{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:09:39Z","timestamp":1791083379227,"version":"4.1.0"},"reference-count":42,"publisher":"IMR Press","issue":"1","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CAPES PrInt UNIFESP","award":["88881.310735\/2018-01"],"award-info":[{"award-number":["88881.310735\/2018-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Older individuals are more likely to develop solid cancers, but at the same time are more sensitive to the side effects of chemotherapy. In addition, older adults are more likely to present with chronic diseases (comorbidities) and immunosenescence that may decrease immunosurveillance against cancer. Clinical outcomes for the older patient with cancer are different from the younger patient and require different research and treatment approaches. Thus, alternative therapeutic approaches tailored specifically to the older patients are required. Colorectal cancer (CRC) has a high incidence in older individuals and is the third leading cause of cancer death globally. Anti-hypertensives are used by a large proportion of older patients and some studies have pointed to a positive impact of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) on CRC outcomes. As we have previously shown in a mouse model, lung metastases express ACE and contain many infiltrating myeloid-derived suppressor cells (MDSC); particularly high levels of MDSC are also present in the blood of older patients with CRC and other cancers, and are associated with disease severity. In this Commentary, we hypothesize that one mechanism responsible for the positive impact of ACEi or ARB on the outcome of CRC is the modulation of myeloid cells contributing to their maturation to non-suppressive neutrophils\/monocytes and diverting them away from retaining an immature MDSC phenotype.<\/jats:p>","DOI":"10.31083\/j.fbl2801002","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T09:20:10Z","timestamp":1673601610000},"source":"Crossref","is-referenced-by-count":11,"title":["Alternative Chemotherapies: Angiotensin-Converting Enzyme Inhibitors Reduce Myeloid-Derived Suppressor Cells to Benefit Older Patients with Colorectal Cancer"],"prefix":"10.31083","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8954-129X","authenticated-orcid":true,"given":"Valquiria","family":"Bueno","sequence":"first","affiliation":[{"name":"Department of Microbiology Immunology and Parasitology, UNIFESP, 04023-0900 S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-0343","authenticated-orcid":true,"given":"Nora Manoukian","family":"Forones","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Gastrointestinal Oncology, UNIFESP, 04023-0900 S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3600-0163","authenticated-orcid":true,"given":"Graham","family":"Pawelec","sequence":"first","affiliation":[{"name":"Department of Immunology, University of T\u00fcbingen, 72074 T\u00fcbingen, Germany"},{"name":"Health Sciences North Research Institute, Sudbury, ON P3E 2H3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"ref1","unstructured":"United Nations. World population prospects 2019: Highlights. 2019. Available at: https:\/\/www.un.org\/development\/desa\/publications\/world-population-prospects-2019-highlights.html (Accessed: 20 October 2022)."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Soto-Perez-de-Celis E, Li D, Yuan Y, Lau YM, Hurria A. Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer. The Lancet Oncology. 2018; 19: e305\u2013e316.","DOI":"10.1016\/S1470-2045(18)30348-6"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"St Sauver JL, Boyd CM, Grossardt BR, Bobo WV, Finney Rutten LJ, Roger VL, et al. Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. BMJ Open. 2015; 5: e006413.","DOI":"10.1136\/bmjopen-2014-006413"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"B\u00e4hler C, Huber CA, Br\u00fcngger B, Reich O. Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study. BMC Health Services Research. 2015; 15: 23.","DOI":"10.1186\/s12913-015-0698-2"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Sambamoorthi U, Tan X, Deb A. Multiple chronic conditions and healthcare costs among adults. Expert Review of Pharmacoeconomics & Outcomes Research. 2015; 15: 823\u2013832.","DOI":"10.1586\/14737167.2015.1091730"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ. Age and cancer risk: a potentially modifiable relationship. American Journal of Preventive Medicine. 2014; 46: S7\u201315.","DOI":"10.1016\/j.amepre.2013.10.029"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013; 153: 1194\u20131217.","DOI":"10.1016\/j.cell.2013.05.039"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"de Magalh\u00e3es JP. How ageing processes influence cancer. Nature Reviews Cancer. 2013; 13: 357\u2013365.","DOI":"10.1038\/nrc3497"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA: A Cancer Journal for Clinicians. 2020; 70: 145\u2013164.","DOI":"10.3322\/caac.21601"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. The Journal of the American Medical Association. 2021; 325: 669\u2013685.","DOI":"10.1001\/jama.2021.0106"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Aguiar Junior S, Oliveira MMD, Silva DRME, Mello CALD, Calsavara VF, Curado MP. Survival of Patients with Colorectal Cancer in a Cancer Center. Arquivos de Gastroenterologia. 2020; 57: 172\u2013177.","DOI":"10.1590\/s0004-2803.202000000-32"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Alves AS, Ishimura ME, Duarte YADO, Bueno V. Parameters of the Immune System and Vitamin D Levels in Old Individuals. Frontiers in Immunology. 2018; 9: 1122.","DOI":"10.3389\/fimmu.2018.01122"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Alves AS, Bueno V. Immunosenescence: participation of T lymphocytes and myeloid-derived suppressor cells in aging-related immune response changes. Einstein. 2019; 17: eRB4733.","DOI":"10.31744\/einstein_journal\/2019RB4733"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Bueno V, Sant\u2019Anna OA, Lord JM. Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease. Age 2014; 36: 9729.","DOI":"10.1007\/s11357-014-9729-x"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Edwards BK, Noone A, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual Report to the Nation on the status of cancer, 1975\u20132010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014; 120: 1290\u20131314.","DOI":"10.1002\/cncr.28509"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Yancik R, Ganz PA, Varricchio CG, Conley B. Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. Journal of Clinical Oncology. 2001; 19: 1147\u20131151.","DOI":"10.1200\/JCO.2001.19.4.1147"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"van Erning FN, Zanders MM, Kuiper JG, van Herk-Sukel MP, Maas HA, Vingerhoets RW, et al. Drug dispensings among elderly in the year before colon cancer diagnosis versus matched cancer-free controls. Journal of Clinical Pharmacy and Therapeutics. 2016; 41: 538\u2013545.","DOI":"10.1111\/jcpt.12434"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Fu AZ, Zhao Z, Gao S, Barber B, Liu GG. Comorbid Conditions in Patients With Metastatic Colorectal Cancer. World Journal of Oncology. 2011; 2: 225\u2013231.","DOI":"10.4021\/wjon370e"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Dai Y, Wang J, Zhu J, Lin J, Yu C, Li Y. Angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis. Cancer Causes and Control. 2015; 26: 1245\u20131255.","DOI":"10.1007\/s10552-015-0617-1"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Asgharzadeh F, Hassanian SM, Ferns GA, Khazaei M, Hasanzadeh M. The Therapeutic Potential of Angiotensin-converting Enzyme and Angiotensin Receptor Inhibitors in the Treatment of Colorectal Cancer: Rational Strategies and Recent Progress. Current Pharmaceutical Design. 2018; 24: 4652\u20134658.","DOI":"10.2174\/1381612825666190111145140"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Cheung KS, Chan EW, Seto WK, Wong ICK, Leung WK. ACE (Angiotensin-Converting Enzyme) Inhibitors\/Angiotensin Receptor Blockers Are Associated With Lower Colorectal Cancer Risk: A Territory-Wide Study With Propensity Score Analysis. Hypertension. 2020; 76: 968\u2013975.","DOI":"10.1161\/HYPERTENSIONAHA.120.15317"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Balkrishnan R, Desai RP, Narayan A, Camacho FT, Flausino LE, Chammas R. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: A Medicare SEER cohort analysis. Cancer Medicine. 2021; 10: 5347\u20135357.","DOI":"10.1002\/cam4.4088"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Morris ZS, Saha S, Magnuson WJ, Morris BA, Borkenhagen JF, Ching A, et al. Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Cancer. 2016; 122: 2487\u20132495.","DOI":"10.1002\/cncr.30079"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Engineer DR, Burney BO, Hayes TG, Garcia JM. Exposure to ACEI\/ARB and \u03b2-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer. Translational Oncology. 2013; 6: 539\u2013545.","DOI":"10.1593\/tlo.13346"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Zeman M, Ska\u0142ba W, Szyma\u0144ski P, Hadasik G, \u017baworonkow D, Walczak DA, et al. Risk factors for long-term survival in patients with ypN+\u2009M0 rectal cancer after radical anterior resection. BMC Gastroenterology. 2022; 22: 141.","DOI":"10.1186\/s12876-022-02226-9"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Rosin FCP, Pedregosa JF, de Almeida JS, Bueno V. Identification of myeloid-derived suppressor cells and T regulatory cells in lung microenvironment after Urethane-induced lung tumor. International Immunopharmacology. 2011; 11: 873\u2013878.","DOI":"10.1016\/j.intimp.2010.12.025"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Teixeira D, Almeida JSD, Visniauskas B, Gomes GN, Hirata AE, Bueno V. Myeloid-derived suppressor cells and associated events in urethane-induced lung cancer. Clinics. 2013; 68: 858\u2013864.","DOI":"10.6061\/clinics\/2013(06)22"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Pereira FV, Arruda DC, Figueiredo CR, Massaoka MH, Matsuo AL, Bueno V, et al. FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system. Clinics. 2013; 68: 1018\u20131027.","DOI":"10.6061\/clinics\/2013(07)21"},{"key":"ref29","unstructured":"Ribeiro J, Visniauskas B, Gomes GN, Bueno V. Evaluation of myeloid-derived suppressor cells and components of renin angiotensin system in Urethane induced lung cancer. Journal of Immunology Research. 2015; 2: id1018"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Bueno V, Mandaliti AL, Forones NM. Colorectal cancer: ageing, myeloid-derived suppressor cells, and treatment: report of two cases. Journal of Cancer Research and Therapeutics. 2018; 6: 25\u201331.","DOI":"10.14312\/2052-4994.2018-4"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Bueno V, Destro P, Teixeira D, Frasca D. Angiotensin converting enzyme (ACE) expression in leukocytes of older adults. medRxiv. 2022. (preprint)","DOI":"10.1101\/2022.07.27.22278062"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Law AMK, Valdes-Mora F, Gallego-Ortega D. Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer. Cells. 2020; 9: 561.","DOI":"10.3390\/cells9030561"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"De Cicco P, Ercolano G, Ianaro A. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion. Frontiers in Immunology. 2020; 11: 1680.","DOI":"10.3389\/fimmu.2020.01680"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Eriksson E, Wenthe J, Irenaeus S, Loskog A, Ullenhag G. Gemcitabine reduces MDSCs, tregs and TGF\u03b2-1 while restoring the teff\/treg ratio in patients with pancreatic cancer. Journal of Translational Medicine. 2016; 14: 282.","DOI":"10.1186\/s12967-016-1037-z"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Vincent J, Mignot G, Chalmin F, Ladoire S, Bruchard M, Chevriaux A, et al. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Research. 2010; 70: 3052\u20133061.","DOI":"10.1158\/0008-5472.CAN-09-3690"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Leong SS, Wee J, Rajan S, Toh CK, Lim WT, Hee SW, et al. Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma. Cancer. 2008; 113: 1332\u20131337.","DOI":"10.1002\/cncr.23687"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, Veenstra R, et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood. 2010; 116: 5738\u20135747.","DOI":"10.1182\/blood-2010-06-287839"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Research. 2005; 65: 3044\u20133048.","DOI":"10.1158\/0008-5472.CAN-04-4505"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nature Reviews Immunology. 2005; 5: 641\u2013654.","DOI":"10.1038\/nri1668"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"de Almeida Nagata DE, Chiang EY, Jhunjhunwala S, Caplazi P, Arumugam V, Modrusan Z, et al. Regulation of Tumor-Associated Myeloid Cell Activity by CBP\/EP300 Bromodomain Modulation of H3K27 Acetylation. Cell Reports. 2019; 27: 269\u2013281.e4.","DOI":"10.1016\/j.celrep.2019.03.008"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Shen XZ, Okwan-Duodu D, Blackwell W, Ong FS, Janjulia T, Bernstein EA, et al. Myeloid expression of angiotensin-converting enzyme facilitates myeloid maturation and inhibits the development of myeloid-derived suppressor cells. Laboratory Investigation. 2014; 94: 536\u2013544.","DOI":"10.1038\/labinvest.2014.41"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Cho WK, Shin S, Kim S, Hong C, Choi C, Park W, et al. Immunomodulatory effect of captopril and local irradiation on myeloid-derived suppressor cells. Radiation Oncology Journal. 2016; 34: 223\u2013229.","DOI":"10.3857\/roj.2016.01816"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/28\/1\/10.31083\/j.fbl2801002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T12:32:36Z","timestamp":1732710756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/28\/1\/10.31083\/j.fbl2801002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"alternative-id":["S2768-6701(22)00747-X"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2801002","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"article-number":"2"}}